Bio Techne reported $128.39M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agilent A:US USD 1.86B 41M
Becton, Dickinson and BDX:US USD 7.63B 186M
Bio Rad Laboratories BIO:US USD 570.68M 43.04M
Bio Techne TECH:US USD 128.39M 9.23M
Bruker BRKR:US USD 864.6M 46.2M
Catalent CTLT:US USD 943M 129M
Charles River Laboratories CRL:US USD 1.01B 33.94M
Danaher DHR:US USD 8.39B 387M
Enzo Biochem ENZ:US USD 24.25M 297K
Exact Sciences EXAS:US USD 423.68M 19.65M
Fluidigm FLDM:US USD 46.17M 3.4M
Hologic HOLX:US USD 956.2M 18.5M
Illumina ILMN:US USD 2.67B 212M
IQVIA Holdings Inc IQV:US USD 5.25B 149M
Merck MRK:GR EUR 9.41B 306M
Mettler Toledo International MTD:US USD 1.16B 46.36M
Nanostring Technologies NSTG:US USD 50.94M 905K
Orasure Technologies OSUR:US USD 71.7M 6.21M
Pacific Biosciences Of California PACB:US USD 81.65M 2.75M
Perkinelmer PKI:US USD 1.49B 441.92M
Repligen RGEN:US USD 410.7M 12.83M
Thermo Fisher Scientific TMO:US USD 17.11B 6B
Waters WAT:US USD 731.97M 14.59M